Підписатись
Вінницький національний медичний університет імені М.І. Пирогова
Вінницький національний медичний університет імені М.І. Пирогова
National Pirogov Memorial Medical University, Vinnytsya
Підтверджена електронна адреса в vnmu.edu.ua - Домашня сторінка
Назва
Посилання
Посилання
Рік
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
58092013
Dapagliflozin and cardiovascular outcomes in type 2 diabetes
SD Wiviott, I Raz, MP Bonaca, O Mosenzon, ET Kato, A Cahn, ...
New England Journal of Medicine 380 (4), 347-357, 2019
56852019
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England journal of medicine 376 (18), 1713-1722, 2017
55672017
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
49622019
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
K Swedberg, M Komajda, M Böhm, JS Borer, I Ford, A Dubost-Brama, ...
The Lancet 376 (9744), 875-885, 2010
33202010
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ...
New England journal of medicine 369 (14), 1327-1335, 2013
30942013
Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia
DL Bhatt, PG Steg, M Miller, EA Brinton, TA Jacobson, SB Ketchum, ...
New England Journal of Medicine 380 (1), 11-22, 2019
28402019
Alirocumab and cardiovascular outcomes after acute coronary syndrome
GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, ...
New England Journal of Medicine 379 (22), 2097-2107, 2018
26222018
Rivaroxaban with or without aspirin in stable cardiovascular disease
JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ...
New England Journal of Medicine 377 (14), 1319-1330, 2017
23522017
Long-term use of ticagrelor in patients with prior myocardial infarction
MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ...
New England Journal of Medicine 372 (19), 1791-1800, 2015
21392015
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ...
New England Journal of Medicine 367 (12), 1087-1097, 2012
15592012
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
K Fox, I Ford, PG Steg, M Tendera, R Ferrari
The Lancet 372 (9641), 807-816, 2008
14642008
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13312018
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1238-1251, 2008
12612008
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ...
New England Journal of Medicine 380 (16), 1509-1524, 2019
10872019
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
G Roe, M.T., Armstrong, P.W., Fox, K.A.A., (...), Rafael, A., Aycock
New England Journal of Medicine, 2012
10812012
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...
Jama 321 (1), 69-79, 2019
10752019
Telmisartan to prevent recurrent stroke and cardiovascular events
S Yusuf, HC Diener, RL Sacco, D Cotton, S Ôunpuu, WA Lawton, ...
New England Journal of Medicine 359 (12), 1225-1237, 2008
10392008
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
9252018
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with …
DH Yoo, P Hrycaj, P Miranda, E Ramiterre, M Piotrowski, S Shevchuk, ...
Annals of the rheumatic diseases 72 (10), 1613-1620, 2013
7972013
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20